Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.

by Eric Fitzsimmons

Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.

by Thomas Celona

People with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.

by Thomas Celona

Advocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.

by Eric Fitzsimmons

What people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.

by Kevin McLaughlin

Forward Look

Tests currently in development seek to offer greater accuracy and reach more people.

by Eric Fitzsimmons

AACR highlights team research that led to Lynch syndrome testing for all people with endometrial cancer in the U.K.

by Marci A. Landsmann

Phase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.

by Thomas Celona

As more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.

by Kevin McLaughlin

Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.

by Eric Fitzsimmons